Actively Recruiting
Liraglutide in Preventing Delirium in Diabetic Elderly After Cardiac Surgery
Led by The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · Updated on 2024-12-20
260
Participants Needed
1
Research Sites
175 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to clarify the preventive effect of perioperative liraglutide application on postoperative delirium in elderly patients with Type 2 diabetes undergoing cardiac surgery.
CONDITIONS
Official Title
Liraglutide in Preventing Delirium in Diabetic Elderly After Cardiac Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 60 years or older
- Diagnosis of Type 2 diabetes
- Scheduled for elective cardiac surgery
You will not qualify if you...
- History of neurological or psychiatric disorders such as schizophrenia, epilepsy, Parkinson's disease, or severe dementia
- Severe communication difficulties including visual, auditory, or speech impairments
- History of central nervous system damage or surgery
- Cardiac function classified as NYHA Class IV
- Severe liver dysfunction (Child-Pugh Class C)
- Severe renal failure requiring renal replacement therapy
- History of pancreatitis
- Diagnosis of Type 1 diabetes
- Blood sugar not controlled within 4-8 mmol/L during screening
- Medullary thyroid carcinoma or family history of it
- Pregnant or breastfeeding women
- Allergy or intolerance to liraglutide
- Previous use of GLP-1A or SGLT2i medications
- Refusal to provide informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Wenxue liu
Nanjing, Jiangsu, China, 210000
Actively Recruiting
Research Team
W
Wenxue Liu, PhD，MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here